JNJ-64565111 Uses, Dosage, Side Effects and more
JNJ-64565111 is under investigation in clinical trial NCT03606057 (A Study to Investigate the Effect of JNJ-64565111 on Cardiac Repolarization (Corrected QT Interval) Compared With Placebo in Healthy Adults: a Thorough ECG Study Employing Placebo, JNJ-64565111, and a Positive Control (Moxifloxacin)).
| Trade Name | JNJ-64565111 |
| Generic | Efinopegdutide |
| Efinopegdutide Other Names | Efinopegdutide, JNJ-64565111 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
